{"id":"hdm1005-1","safety":{"commonSideEffects":[]},"_chembl":null,"_dailymed":null,"mechanism":{"_ai_source":"groq-llama-8b","explanation":"Unfortunately, I do not have information on the specific mechanism of action of HDM1005 1.","oneSentence":"HDM1005 1 is a small molecule drug.","_ai_confidence":"low"},"_scrapedAt":"2026-03-28T01:15:02.159Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"phase_3"}]},"trialDetails":[{"nctId":"NCT07417306","phase":"PHASE3","title":"A Study of HDM1005 in Participants With T2DM Not Controlled With Metformin Alone or in Combination With a Sodium-Glucose Cotransporter 2 (SGLT2) Inhibitor","status":"NOT_YET_RECRUITING","sponsor":"Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd.","startDate":"2026-03-27","conditions":"Type 2 Diabetes","enrollment":912},{"nctId":"NCT07394114","phase":"PHASE3","title":"A Study of HDM1005 in Participants With Type 2 Diabetes Not Controlled With Diet and Exercise Alone","status":"RECRUITING","sponsor":"Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd.","startDate":"2026-02-24","conditions":"Type 2 Diabetes","enrollment":240},{"nctId":"NCT06637020","phase":"PHASE1","title":"Phase Ib Clinical Study of HDM1005 Injection","status":"COMPLETED","sponsor":"Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd.","startDate":"2024-06-20","conditions":"Overweight and Obesity","enrollment":40},{"nctId":"NCT06640647","phase":"PHASE1","title":"Phase Ia Clinical Study of HDM1005 Injection","status":"COMPLETED","sponsor":"Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd.","startDate":"2024-03-19","conditions":"Obesity and Overweight","enrollment":65},{"nctId":"NCT07279194","phase":"PHASE3","title":"Efficacy and Safety of HDM1005 in Chinese Obesity or Overweight Patients Without Diabetes","status":"RECRUITING","sponsor":"Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd.","startDate":"2025-10-14","conditions":"Obesity & Overweight","enrollment":825},{"nctId":"NCT06886126","phase":"PHASE2","title":"Phase II Clinical Study of HDM1005 Injection in Obese Adults Without Diabetes Mellitus","status":"RECRUITING","sponsor":"Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd.","startDate":"2025-02-07","conditions":"Obesity","enrollment":240},{"nctId":"NCT07109700","phase":"PHASE2","title":"A Study of HDM1005 in Participants With T2DM Not Controlled With Diet/Exercise or Metformin","status":"RECRUITING","sponsor":"Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd.","startDate":"2025-04-30","conditions":"Type 2 Diabetes","enrollment":216}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":10168283,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"phase_3","status":"active","brandName":"HDM1005 1","genericName":"HDM1005 1","companyName":"Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd.","companyId":"hangzhou-zhongmei-huadong-pharmaceutical-co-ltd","modality":"Small molecule","firstApprovalDate":"","aiSummary":"HDM1005 1 is a small molecule drug. Used for phase_3.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":false,"trials":true,"score":3}}